111 related articles for article (PubMed ID: 807755)
21. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
[TBL] [Abstract][Full Text] [Related]
22. Gentamicin in the treatment of pulmonary infections.
Louria DB; Young L; Armstrong D; Smith JK
J Infect Dis; 1969; 119(4):483-5. PubMed ID: 4977999
[No Abstract] [Full Text] [Related]
23. [Clinical trials with amoxicillin (Pasetocin 'Kyowa') on infections of respiratory apparatus (author's transl)].
Horiuchi N; Ohkawara N; Abu Y; Hattori Y; Sato K
Jpn J Antibiot; 1976 Mar; 29(3):332-9. PubMed ID: 1271587
[TBL] [Abstract][Full Text] [Related]
24. Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections.
Pines A; Khaja G; Raafat H; Sreedharan KS
Chemotherapy; 1974; 20(1):39-44. PubMed ID: 4210892
[No Abstract] [Full Text] [Related]
25. [Distribution and drug-resistance of 345 strains gram-negative bacilli from hospitalized patients with lower respiratory tract infections diseases].
Li Y; Zhao Y; Wang K
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):588-9. PubMed ID: 11477872
[TBL] [Abstract][Full Text] [Related]
26. Respiratory tract infection caused by bacteria (non-Mycobacterium) and their antibiogram in HIV-positive patients.
Srifuengfung S; Tribuddharat C; Yungyuen T; Wensentia T
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):709-12. PubMed ID: 16124443
[TBL] [Abstract][Full Text] [Related]
27. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
[TBL] [Abstract][Full Text] [Related]
28. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1981)].
Ikemoto H; Watanabe K; Kosakai N; Igari J; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Konishi K
Jpn J Antibiot; 1983 Nov; 36(11):2925-50. PubMed ID: 6425535
[TBL] [Abstract][Full Text] [Related]
29. Roxithromycin (RU 28965) in the treatment of respiratory tract infections.
Grassi C; Bertoletti R; De Rose V; Manara G; Mangiarotti P
Chemioterapia; 1987 Feb; 6(1):41-4. PubMed ID: 3103931
[TBL] [Abstract][Full Text] [Related]
30. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
[TBL] [Abstract][Full Text] [Related]
31. [On the acute respiratory infections of anaerobes bacteria: clinical, bacteriological and therapeutic results (author's transl)].
Moroni M; Marca G; Privitera G; Ramusino AC
Ann Sclavo; 1976; 18(2):338-56. PubMed ID: 827988
[TBL] [Abstract][Full Text] [Related]
32. [Susceptibility of bacterial isolates from the equine respiratory tract to trimethoprim, sulfadoxine, sulfadimethoxine and combinations of these compounds].
Fey K; Schmid P
Tierarztl Prax; 1995 Apr; 23(2):148-54. PubMed ID: 7624856
[TBL] [Abstract][Full Text] [Related]
33. Clinical effectiveness of lividomycin on urinary tract infections: evaluation with double-blind method.
Kumazawa J; Momose S
Curr Ther Res Clin Exp; 1973 Dec; 15(12):873-901. PubMed ID: 4203572
[No Abstract] [Full Text] [Related]
34. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
[TBL] [Abstract][Full Text] [Related]
35. [Sensitivity of frequent-occurring isolates in outpatients to routinely-used antibiotics (author's transl)].
Deguchi K
Jpn J Antibiot; 1979 Jun; 32(6):668-74. PubMed ID: 381708
[TBL] [Abstract][Full Text] [Related]
36. [Pathogenic and clinical changes of pneumonia in the recent 10 years].
Jiang XF
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):336-8, 379. PubMed ID: 2128219
[TBL] [Abstract][Full Text] [Related]
37. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
38. Multicentered clinical evaluation of cefoperazone for the treatment of lower respiratory tract infections.
Gardner WG
Rev Infect Dis; 1983; 5 Suppl 1():S137-44. PubMed ID: 6221383
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract].
Chuchalin AG; Novikov IuK; Avdeev SN; Belevskiĭ AS
Antibiot Khimioter; 1997; 42(6):34-8. PubMed ID: 9313057
[TBL] [Abstract][Full Text] [Related]
40. Position of ceftazidime in respiratory diseases.
Ando' F; Girbino G; Ferrara F
Drugs Exp Clin Res; 1985; 11(6):369-72. PubMed ID: 3915288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
